Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Accelerate Diagnostics, Inc. AXDX
$0.75
-$0 (-0.04%)
На 18:00, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
75378696.00000000
-
week52high
3.74
-
week52low
0.45
-
Revenue
12752000
-
P/E TTM
-3
-
Beta
1.17162600
-
EPS
-0.73000000
-
Last Dividend
0.00000000
-
Next Earnings Date
11 мая 2023 г. в 10:59
Описание компании
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Craig-Hallum | Hold | Buy | 09 мар 2022 г. |
| BTIG | Neutral | 08 окт 2020 г. | |
| Piper Sandler | Overweight | Overweight | 10 авг 2020 г. |
| JP Morgan | Underweight | Neutral | 27 сент 2019 г. |
| JP Morgan | Neutral | Overweight | 07 ноя 2018 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Phillips Jack | D | 0 | 10000 | 01 февр 2023 г. |
| Phillips Jack | A | 260843 | 10000 | 01 февр 2023 г. |
| Phillips Jack | D | 0 | 17216 | 13 янв 2023 г. |
| Phillips Jack | D | 250843 | 8408 | 13 янв 2023 г. |
| Phillips Jack | A | 259251 | 17216 | 13 янв 2023 г. |
| REICHLING STEVEN | D | 0 | 9439 | 13 янв 2023 г. |
| REICHLING STEVEN | D | 72202 | 4730 | 13 янв 2023 г. |
| REICHLING STEVEN | A | 76932 | 9439 | 13 янв 2023 г. |
| Mertz Larry Michael | A | 433411 | 50000 | 30 авг 2022 г. |
| Mertz Larry Michael | A | 383411 | 51749 | 22 авг 2022 г. |
Новостная лента
Accelerate Diagnostics, Inc. (AXDX) Q1 2023 Earnings Call Transcript
Seeking Alpha
11 мая 2023 г. в 22:36
Accelerate Diagnostics, Inc. (NASDAQ:AXDX ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Laura Pierson - Investor Relations Jack Phillips - President & Chief Executive Officer David Patience - Chief Financial Officer Conference Call Participants Andrew Brackmann - William Blair Operator Good day, and welcome to the Accelerate Diagnostics Incorporated 2023 Q1 Results Conference Call. All participants will be in listen-only mode.
Accelerate Diagnostics (AXDX) Reports Q1 Loss, Misses Revenue Estimates
Zacks Investment Research
11 мая 2023 г. в 19:02
Accelerate Diagnostics (AXDX) came out with a quarterly loss of $0.17 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.25 per share a year ago.
Forget Bargain Hunting, Buy 5 Stocks With Rising P/E
Zacks Investment Research
18 апр 2023 г. в 08:24
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Disney (DIS), Casey's General Stores (CASY), OpGen (OPGN), Accelerate Diagnostics (AXDX) and Nektar Therapeutics (NKTR).
Accelerate Diagnostics (AXDX) Upgraded to Buy: What Does It Mean for the Stock?
Zacks Investment Research
03 апр 2023 г. в 13:41
Accelerate Diagnostics (AXDX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Accelerate Diagnostics, Inc. (AXDX) Q4 2022 Earnings Call Transcript
Seeking Alpha
29 мар 2023 г. в 22:22
Accelerate Diagnostics, Inc. (NASDAQ:AXDX ) Q4 2022 Earnings Conference Call March 29, 2023 4:30 PM ET Company Participants Laura Pierson - IR Jack Phillips - President and CEO Steve Reichling - outgoing-CFO David Patience - incoming-CFO Conference Call Participants Alex Nowak - Craig-Hallum Dustin Scaringe - William Blair Operator Good afternoon, and welcome to the Accelerate Diagnostics Fourth Quarter 2022 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.